Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1493356
PUBLISHER: Grand View Research | PRODUCT CODE: 1493356
U.S. Immunoassay Market Size, Share & Trends Analysis Report By Product (Reagent & Kits, Analyzers/Instruments), By Technology (RIA, ELISA), By Application, By Specimen, By End-use, By Region, And Segment Forecasts, 2024 - 2030
PUBLISHED:
PAGES: 70 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
U.S. Immunoassay Market Growth & Trends:
The U.S. immunoassay market is anticipated to reach USD 12.25 billion by 2030 and is projected to grow at a CAGR of 2.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing incidence of chronic and infectious diseases and rising demand for early detection of diseases are the major factors contributing to the market growth. According to the International Agency for Research on Cancer, 19,292,789 cancer cases were reported in 2020 and are expected to reach 50,550,287 by 2025. Breast, lung, colorectum, prostate, and stomach are the most common cancers reported.
The rising geriatric population is a significant factor driving the market growth in the U.S. As more individuals reach retirement age and require medical care, the demand for diagnostic tests such as immunoassays is expected to rise. Furthermore, technological advancements such as automation, miniaturization, point-of-care testing devices, and advanced detection technologies are key drivers of the immunoassay market. These innovations have revolutionized immunoassay techniques, making them more efficient, reliable, and accessible for a wide range of applications in healthcare and research.
The growing adoption of immunoassay tests in clinical diagnostics and research laboratories has positively impacted the U.S. market by driving market expansion, fostering innovation in assay development, and improving patient outcomes through early and accurate diagnosis.
U.S. Immunoassay Market Report Highlights:
- Reagents & kits led the market with the largest revenue share of 65.82% in 2023 and are expected to grow at the fastest CAGR over the forecast period, owing to the increasing introduction and approval of innovative immunoassay kits
- Based on application, the infectious diseases testing segment led the market with the largest revenue share of 29.55% in 2023, due to increasing demand for immunoassays for early detection of infectious diseases such as HIV, hepatitis, COVID-19, and others
- Based on end-use, the hospital segments held the market with the largest revenue share of 33.01% in 2023. Hospitals are considered primary care facilities for the diagnosis of various diseases, which is driving segment growth
- Based on specimen, the blood segment led the market with the largest revenue share of 43.19% in 2023, owing to the increasing incidence of diseases requiring these blood testing procedures and technological advancements in the segment
- In July 2023, SEKISUI Diagnostics introduced the OSOM COVID-19 Antigen Home Test, made in the U.S. The test can be performed at home and is likely to help detect nucleocapsid protein antigen that results from the SARS-CoV-2 virus
Product Code: GVR-4-68040-285-5
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Technology
- 1.2.3. Application
- 1.2.4. End-use
- 1.2.5. Specimen
- 1.2.6. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Volume price analysis (Model 2)
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Technology outlook
- 2.2.3. Application outlook
- 2.2.4. End-use outlook
- 2.2.5. Specimen outlook
- 2.3. Competitive Insights
Chapter 3. U.S. Immunoassay Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
- 3.3. U.S. Immunoassay Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Technological landscape
- 3.3.2.5. Legal landscape
- 3.3.2.6. Environmental landscape
- 3.3.1. Industry Analysis - Porter's
Chapter 4. U.S. Immunoassay Market: Product Estimates & Trend Analysis
- 4.1. Product Market Share, 2023 & 2030
- 4.2. Segment Dashboard
- 4.3. U.S. Immunoassay Market by Product Outlook
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 For The Following
- 4.4.1. Reagents & kits
- 4.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.1.2. ELISA reagents & kits
- 4.4.1.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.1.3. Rapid test reagents & kits
- 4.4.1.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.1.4. ELISPOT reagents & kits
- 4.4.1.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.1.5. Western blot reagents & kits
- 4.4.1.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.1.6. Other reagents & kits
- 4.4.1.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.2. Analyzers/instruments
- 4.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.2.2. Open ended systems
- 4.4.2.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.2.3. Closed ended systems
- 4.4.2.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.3. Software & Services
- 4.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.1. Reagents & kits
Chapter 5. U.S. Immunoassay Market: Technology Estimates & Trend Analysis
- 5.1. Technology Market Share, 2023 & 2030
- 5.2. Segment Dashboard
- 5.3. U.S. Immunoassay Market by Technology Outlook
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 For The Following
- 5.4.1. Radioimmunoassay (RIA)
- 5.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4.2. Enzyme Immunoassays (EIA)
- 5.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4.2.2. Chemiluminescence Immunoassays (CLIA)
- 5.4.2.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4.2.3. Fluorescence Immunoassays (FIA)
- 5.4.2.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4.3. Rapid test
- 5.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4.4. Others
- 5.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4.1. Radioimmunoassay (RIA)
Chapter 6. U.S. Immunoassay Market: Application Estimates & Trend Analysis
- 6.1. Application Market Share, 2023 & 2030
- 6.2. Segment Dashboard
- 6.3. U.S. Immunoassay Market by Application Outlook
- 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 For The Following
- 6.4.1. Therapeutic drug monitoring
- 6.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.4.2. Oncology
- 6.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.4.3. Cardiology
- 6.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.4.4. Endocrinology
- 6.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.4.5. Infectious disease testing
- 6.4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.4.6. Autoimmune diseases
- 6.4.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.4.7. Others
- 6.4.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.4.1. Therapeutic drug monitoring
Chapter 7. U.S. Immunoassay Market: End-use Estimates & Trend Analysis
- 7.1. End-use Market Share, 2023 & 2030
- 7.2. Segment Dashboard
- 7.3. U.S. Immunoassay Market by End-use Outlook
- 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 For The Following
- 7.4.1. Hospitals
- 7.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.4.2. Blood banks
- 7.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.4.3. Clinical laboratories
- 7.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.4.4. Pharmaceutical and biotech companies
- 7.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.4.5. Academic research centers
- 7.4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.4.6. Others
- 7.4.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.4.1. Hospitals
Chapter 8. U.S. Immunoassay Market: Specimen Estimates & Trend Analysis
- 8.1. Specimen Market Share, 2023 & 2030
- 8.2. Segment Dashboard
- 8.3. U.S. Immunoassay Market by Specimen Outlook
- 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 For The Following
- 8.4.1. Blood
- 8.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 8.4.2. Saliva
- 8.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 8.4.3. Urine
- 8.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 8.4.4. Other specimens
- 8.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 8.4.1. Blood
Chapter 9. U.S. Immunoassay Market: Region Estimates & Trend Analysis
- 9.1. Regional Market Share, 2023 & 2030
- 9.2. U.S. Immunoassay Market by Region Outlook
- 9.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 9.3.1. West
- 9.3.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 9.3.2. Midwest
- 9.3.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 9.3.3. Northeast
- 9.3.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 9.3.4. Southwest
- 9.3.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 9.3.5. Southeast
- 9.3.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 9.3.1. West
Chapter 10. Competitive Landscape
- 10.1. Recent Developments & Impact Analysis, By Key Market Participants
- 10.2. Company/Competition Categorization
- 10.3. Vendor Landscape
- 10.3.1. List of key distributors and channel partners
- 10.3.2. Key customers
- 10.3.3. Key company heat map analysis, 2023
- 10.4. Company Profiles
- 10.4.1. F. Hoffmann-La Roche AG
- 10.4.1.1. Company overview
- 10.4.1.2. Financial performance
- 10.4.1.3. Product benchmarking
- 10.4.1.4. Strategic initiatives
- 10.4.2. Abbott Laboratories
- 10.4.2.1. Company overview
- 10.4.2.2. Financial performance
- 10.4.2.3. Product benchmarking
- 10.4.2.4. Strategic initiatives
- 10.4.3. Siemens Healthineers
- 10.4.3.1. Company overview
- 10.4.3.2. Financial performance
- 10.4.3.3. Product benchmarking
- 10.4.3.4. Strategic initiatives
- 10.4.4. Danaher Corporation
- 10.4.4.1. Company overview
- 10.4.4.2. Financial performance
- 10.4.4.3. Product benchmarking
- 10.4.4.4. Strategic initiatives
- 10.4.5. Thermo Fisher Scientific
- 10.4.5.1. Company overview
- 10.4.5.2. Financial performance
- 10.4.5.3. Product benchmarking
- 10.4.5.4. Strategic initiatives
- 10.4.6. Bio-Rad Laboratories
- 10.4.6.1. Company overview
- 10.4.6.2. Financial performance
- 10.4.6.3. Product benchmarking
- 10.4.6.4. Strategic initiatives
- 10.4.7. Beckman Coulter (a subsidiary of Danaher)
- 10.4.7.1. Company overview
- 10.4.7.2. Financial performance
- 10.4.7.3. Product benchmarking
- 10.4.7.4. Strategic initiatives
- 10.4.8. Sysmex Corporation
- 10.4.8.1. Company overview
- 10.4.8.2. Financial performance
- 10.4.8.3. Product benchmarking
- 10.4.8.4. Strategic initiatives
- 10.4.9. DiaSorin
- 10.4.9.1. Company overview
- 10.4.9.2. Financial performance
- 10.4.9.3. Product benchmarking
- 10.4.9.4. Strategic initiatives
- 10.4.10. Agilent Technologies
- 10.4.10.1. Company overview
- 10.4.10.2. Financial performance
- 10.4.10.3. Product benchmarking
- 10.4.10.4. Strategic initiatives
- 10.4.1. F. Hoffmann-La Roche AG
Product Code: GVR-4-68040-285-5
List of Tables
- Table 1 List of abbreviations
- Table 2 U.S. immunoassay market, by product, 2018 - 2030 (USD Million)
- Table 3 U.S. immunoassay market, by technology, 2018 - 2030 (USD Million)
- Table 4 U.S. immunoassay market, by application, 2018 - 2030 (USD Million)
- Table 5 U.S. immunoassay market, by end use, 2018 - 2030 (USD Million)
- Table 6 U.S. immunoassay market, by specimen, 2018 - 2030 (USD Million)
- Table 7 U.S. immunoassay market, by region, 2018 - 2030 (USD Million)
List of Figures
- Fig. 1 Market research process
- Fig. 2 Data triangulation techniques
- Fig. 3 Primary research pattern
- Fig. 4 Market research approaches
- Fig. 5 Value-chain-based sizing & forecasting
- Fig. 6 QFD modeling for market share assessment
- Fig. 7 Market formulation & validation
- Fig. 8 U.S. immunoassay market: Market outlook
- Fig. 9 U.S. immunoassay competitive insights
- Fig. 10 Parent market outlook
- Fig. 11 Related/ancillary market outlook
- Fig. 12 Penetration and growth prospect mapping
- Fig. 13 U.S. immunoassay market driver impact
- Fig. 14 U.S. immunoassay market restraint impact
- Fig. 15 U.S. immunoassay market: Product movement analysis
- Fig. 16 U.S. immunoassay market: Product outlook and key takeaways
- Fig. 17 Reagents & kits market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 18 Elisa reagents & kits market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 19 Rapid test reagents & kits market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 20 Elispot reagents & kits market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 21 Western blot reagents & kits market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 22 Other reagents & kits market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 23 Analyzers/Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 24 Open ended systems market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 25 Closed ended systems market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 26 Software & services market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 27 U.S. immunoassay Market: Technology movement Analysis
- Fig. 28 U.S. immunoassay market: Technology outlook and key takeaways
- Fig. 29 Radioimmunoassay (RIA) market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 30 Enzyme Immunoassays (EIA) market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 31 Chemiluminescence Immunoassays (CLIA) market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 32 Fluorescence Immunoassays (FIA) market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 33 Rapid test market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 34 Others market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 35 U.S. immunoassay market: Application movement analysis
- Fig. 36 U.S. immunoassay market: Application outlook and key takeaways
- Fig. 37 Therapeutic drug monitoring market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 38 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 39 Cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 40 Endocrinology market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 41 Infectious disease testing market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 42 Autoimmune diseases market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 43 Others market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 44 U.S. immunoassay market: End-use movement analysis
- Fig. 45 U.S. immunoassay market: End-use outlook and key takeaways
- Fig. 46 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 47 Blood banks market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 48 Clinical laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 49 Pharmaceutical and biotech companies market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 50 Academic research centers market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 51 Others market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 52 U.S. immunoassay market: Specimen movement analysis
- Fig. 53 U.S. immunoassay market: Specimen outlook and key takeaways
- Fig. 54 Blood market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 55 Saliva market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 56 Urine market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 57 Other specimens market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 58 U.S. immunoassay market: Regional movement analysis
- Fig. 59 U.S. immunoassay market: Regional outlook and key takeaways
- Fig. 60 West market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 61 Midwest market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 62 Northeast market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 63 Southwest market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 64 Southeast market estimates and forecasts, 2018 - 2030 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.